MRI in prostate cancer: Optimising interpretation by urologists and radiologists

Thematic Session 15

  • Location:
    Room Amsterdam, North Hall (Level 1)
  • Chairs:
     H. Thoeny, Berne (CH)
     A. Villers, Lille (FR)
  • Aims and objectives of this session

    Prostate MRI is more and more frequently present in our patient evaluation for prostate cancer diagnosis, staging and treatment planing. As urologists we need to be confident in reading mpMRI, based on images and report from radiologists. This session will cover the PIRADS 2.0 scoring in clinical practice, the use of MRI guidance for prostate biopsy, and what to expect from your radiologist to get best mpMRI interpretation.

European Society of Urogenital Radiology (ESUR) lecture PI-RADS in clinical practice including differential diagnoses in prostate imaging
 H. Thoeny, Berne (CH)
Reading and interpreting mpMRI: PIRADS 2.0
 M. de Rooij, Nijmegen (NL)
Discussant: Is PIRADS 2.0 standardised enough?
 T. Polascik, Durham (US)
State-of-the-art lecture What do urologists need to know about mpMRI targeted biopsy?
 S. Boxler, Bern (CH)
State-of-the-art lecture Levels of competence in mpMRI reporting
 P. Puech, Lille (FR)
Associated video presentation
Focal therapy with HIFU FocalOne device with MRI target fusion biopsy by KOELIS

By: Potiron E., Nevoux P., Rousseau T., Le Goguic G., Lacoste J.

Institutes: Clinique Urologique Nantes Atlantis, Nantes, France